Clinical trial
An Open Label Study of Aripiprazole in Children and Adolescents With Autism Spectrum Disorders
NCT00619190 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label Study of Aripiprazole in Children and Adolescents With Autism Spectrum Disorders
- Lead sponsor
- University of North Carolina, Chapel Hill
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- June 30, 2012
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.